Enjuvia Interactions
There are 355 drugs known to interact with Enjuvia (conjugated estrogens), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 33 are major, 303 are moderate, and 19 are minor.
- View all 355 medications that may interact with Enjuvia
- View Enjuvia alcohol/food interactions (3)
- View Enjuvia disease interactions (17)
Most frequently checked interactions
View interaction reports for Enjuvia (conjugated estrogens) and the medicines listed below.
- Ambien (zolpidem)
- amitriptyline
- aspirin
- baclofen
- clonazepam
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- gabapentin
- hydrochlorothiazide
- Klonopin (clonazepam)
- levothyroxine
- Lexapro (escitalopram)
- lorazepam
- Lyrica (pregabalin)
- magnesium oxide
- metformin
- Neurontin (gabapentin)
- Nexium (esomeprazole)
- omeprazole
- oxycodone
- phentermine
- Prozac (fluoxetine)
- Seroquel (quetiapine)
- Synthroid (levothyroxine)
- tramadol
- trazodone
- VESIcare (solifenacin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Wellbutrin XL (bupropion)
Enjuvia alcohol/food interactions
There are 3 alcohol/food interactions with Enjuvia (conjugated estrogens).
Enjuvia disease interactions
There are 17 disease interactions with Enjuvia (conjugated estrogens) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
Report options
More about Enjuvia (conjugated estrogens)
- Enjuvia consumer information
- Compare alternatives
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: estrogens
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Evenity
Evenity (romosozumab) injection is used to treat osteoporosis in postmenopausal women to reduce the ...
Norethindrone
Norethindrone systemic is used for abnormal uterine bleeding, amenorrhea, birth control ...
Calcium carbonate
Calcium carbonate systemic is used for duodenal ulcer, erosive esophagitis, GERD, hypocalcemia ...
Testosterone
Testosterone is used in men and boys to treat conditions caused by a lack of this hormone. Includes ...
Tamoxifen
Tamoxifen blocks the actions of estrogen and is used to treat and prevent some types of breast ...
Estradiol
Estradiol is used to treat symptoms of menopause such as hot flashes, and vaginal dryness, burning ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
